www.fdanews.com/articles/131203-mannkind-initiates-phase-ii-trial-of-cancer-vaccine-for-advanced-melanoma
MannKind Initiates Phase II Trial of Cancer Vaccine for Advanced Melanoma
October 19, 2010
MannKind Corporation Tuesday announced the first patient has been dosed in a phase II clinical trial of the novel, investigational cancer vaccine MKC1106-MT.
CNBC
CNBC